The important unresolved issues are: (1) the role of SLC39A8 in intestinal homeostasis; (2) the mechanisms by which SLC39A8 deficiency contributes to the pathophysiology of IBD; and (3) the therapeutic targets for IBD patients with SLC39A8 deficiency. The gene discussed is SLC39A8; the disease is inflammatory bowel disease.